SCHEMBL26322229

SCHEMBL26322229

c1ccc(Nc2ccc3c(c2)-c2ccccc2C3)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.54
CYP1A2 P05177 3/20 0.54
CYP3A4 P08684 3/20 0.54
PPARG P37231 1/20 0.52
SLC6A2 P23975 2/20 0.49
HTR2B P41595 2/20 0.49
ADRA2A P08913 1/20 0.49
MAOA P21397 1/20 0.49
HTR2C P28335 1/20 0.49
SLC6A4 P31645 1/20 0.49
ALDH1A1 P00352 4/20 0.48
MAPT P10636 3/20 0.48
MEN1 O00255 1/20 0.48
AR P10275 1/20 0.48
KMT2A Q03164 1/20 0.48
TSHR P16473 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
ALOX15 P16050 1/20 0.48
ALOX12 P18054 1/20 0.48
PTGS1 P23219 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2522352 0.94 CYP1A2 (0.56) HSD17B10CYP1A2CYP3A4PPARGSLC6A2
SCHEMBL2165580 0.93 CYP1A2 (0.60) HSD17B10CYP1A2CYP3A4SLC6A2HTR2B
SCHEMBL19836623 0.91 CYP1A2 (0.50) HSD17B10CYP1A2CYP3A4PPARGSLC6A2
SCHEMBL1921953 0.89 CYP1A2 (0.64) HSD17B10CYP1A2CYP3A4SLC6A2HTR2B
Diphenylamine SCHEMBL27494289 0.88 HSD17B10 (0.57) HSD17B10CYP1A2CYP3A4PPARGSLC6A2
Diphenylamine SCHEMBL28474170 0.88 HSD17B10 (0.57) HSD17B10CYP1A2CYP3A4PPARGSLC6A2
SCHEMBL24742118 0.87 ALDH1A1 (0.54) HSD17B10CYP1A2CYP3A4PPARGSLC6A2
SCHEMBL7168804 0.86 HSD17B10 (0.54) HSD17B10CYP1A2CYP3A4SLC6A2HTR2B
SCHEMBL2168131 0.86 CYP1A2 (0.66) HSD17B10CYP1A2CYP3A4SLC6A2HTR2B
Diphenylamine SCHEMBL28707010 0.86 HSD17B10 (0.55) HSD17B10CYP1A2CYP3A4PPARGSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023171951-A1 ORGANIC LIGHT-EMITTING DEVICE, METHOD FOR MANUFACTURING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER 엘티소재주식회사 2023-09-14 WO disclosed
US-20230130802-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230130802-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, ELAVL1, EML4 HSD17B10 4537/4885CYP1A2 3837/4885CYP3A4 2219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.